Zarębska-Michaluk D - Search Results

1

Effectiveness of pangenotypic retreatment of chronic hepatitis C after prior failure of pangenotypic therapies.

Jaroszewicz J, Zarębska-Michaluk D, Janocha-Litwin J, Parfieniuk-Kowerda A, Sitko M, Piekarska A, Białkowska J, Dybowska D, Murawska-Ochab A, Flisiak R. Jaroszewicz J, et al. Pol Arch Intern Med. 2023 Mar 29;133(3):16400. doi: 10.20452/pamw.16400. Epub 2023 Jan 5. Pol Arch Intern Med. 2023. PMID: 36602060 Free article.

2

Obligation Is Not a Compulsion-The Quality of the Law and the Effectiveness and Safety of Vaccination against COVID-19.

Kocańda K, Zarębska-Michaluk D. Kocańda K, et al. Int J Environ Res Public Health. 2022 Oct 27;19(21):14003. doi: 10.3390/ijerph192114003. Int J Environ Res Public Health. 2022. PMID: 36360882 Free PMC article.

3

DRB1 alleles in relation to severity of liver disease in patients with chronic hepatitis C.

Kryczka W, Brojer E, Kalińska A, Urbaniak A, Zarebska-Michaluk D. Kryczka W, et al. Med Sci Monit. 2001 May;7 Suppl 1:217-20. Med Sci Monit. 2001. PMID: 12211723

4

[Rate of liver fibrosis progression among patients with chronic hepatitis C in Poland].

Kryczka W, Chrapek M, Paluch K, Zarebska-Michaluk D, Urbaniak A. Kryczka W, et al. Pol Arch Med Wewn. 2003 Aug;110(2):869-75. Pol Arch Med Wewn. 2003. PMID: 14682226 Polish.

5

[Assessment of the usefulness of combination of selected clinical and demographic parameters in prediction of the severity of liver fibrosis in patients with chronic hepatitis C].

Kryczka W, Chrapek M, Zarebska-Michaluk D. Kryczka W, et al. Przegl Epidemiol. 2005;59(2):395-403. Przegl Epidemiol. 2005. PMID: 16190546 Polish.

6

Extrahepatic manifestations associated with chronic hepatitis C infections in Poland.

Zarebska-Michaluk DA, Lebensztejn DM, Kryczka WM, Skiba E. Zarebska-Michaluk DA, et al. Adv Med Sci. 2010;55(1):67-73. doi: 10.2478/v10039-010-0009-4. Adv Med Sci. 2010. PMID: 20371429

7

Megamitochondria formation in hepatocytes of patient with chronic hepatitis C - a case report.

Wieczorek A, Stępień PM, Zarębska-Michaluk D, Kryczka W, Pabjan P, Król T. Wieczorek A, et al. Clin Exp Hepatol. 2017 Sep;3(3):169-175. doi: 10.5114/ceh.2017.68287. Epub 2017 Jun 12. Clin Exp Hepatol. 2017. PMID: 29062908 Free PMC article.

8

Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C.

Kryczka W, Brojer E, Kowalska A, Zarebska-Michaluk D. Kryczka W, et al. Med Sci Monit. 2001 May;7 Suppl 1:221-5. Med Sci Monit. 2001. PMID: 12211724

9

Assessment of selected clinical factors as predictors of response to combined interferon-alpha plus ribavirin therapy among patients with chronic hepatitis C.

Kryczka W, Zarebska-Michaluk D, Chrapek M. Kryczka W, et al. Med Sci Monit. 2003 Aug;9 Suppl 3:32-5. Med Sci Monit. 2003. PMID: 15156609

10

The Effect of Reduced Oxygen Saturation on Retinal Microvascularization in COVID-19 Patients with Bilateral Pneumonia Based on Optical Coherence Tomography Study.

Kal M, Winiarczyk M, Mackiewicz J, Odrobina D, Cieśla E, Płatkowska-Adamska B, Biskup M, Pabjan P, Zarębska-Michaluk D. Kal M, et al. J Pers Med. 2022 Nov 2;12(11):1824. doi: 10.3390/jpm12111824. J Pers Med. 2022. PMID: 36573721 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters